| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/31/1994 | US5317088 Binding |
| 05/31/1994 | US5317084 Process for large-scale production of antimicrobal peptide in high purity |
| 05/31/1994 | US5317011 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| 05/31/1994 | US5316947 Synthetic isohirudins with improved stability |
| 05/31/1994 | US5316937 Conditioned medium useful for sustaining growth of colonic crypt cells |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316923 Synthetic yeast leader peptides |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/27/1994 | CA2102034A1 Antibody and method for its production |
| 05/27/1994 | CA2092494A1 Human cell lines |
| 05/26/1994 | WO1994011535A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 05/26/1994 | WO1994011525A1 Improved recombinant production of proteins having factor viii:c activity |
| 05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
| 05/26/1994 | WO1994011521A1 Bovine heat shock promoter and uses thereof |
| 05/26/1994 | WO1994011514A1 Human endogenous retrovirus-k-envelope-gene encoded glycoprotein, and a monoclonal antibody for diagnostic and therapeutic purposes |
| 05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | WO1994011512A2 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | WO1994011511A1 Biocidal chitin binding proteins |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011508A2 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 05/26/1994 | WO1994011507A2 Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna |
| 05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011502A2 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 05/26/1994 | WO1994011501A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
| 05/26/1994 | WO1994011500A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011496A1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 05/26/1994 | WO1994011495A1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 05/26/1994 | WO1994011404A1 Antibodies for gm-csf receptor and uses thereof |
| 05/26/1994 | WO1994011402A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 05/26/1994 | WO1994011401A1 Human homolog of the e-cadherin gene and methods based thereon |
| 05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011028A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011024A1 Composition protective against p. multocida pasteurellosis infection |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011019A1 Materials and methods for immunocontraception |
| 05/26/1994 | WO1994010856A1 Method of preparing protein hydrolysates low in chromium |
| 05/26/1994 | WO1994009134A3 Modified ciliary neurotrophic factors |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | WO1994002510A3 Analogs of pth |
| 05/26/1994 | WO1994001558A3 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 05/26/1994 | DE4238979A1 Verfahren zur Herstellung chromarmer Proteinhydrolysate Process for the preparation of low-chromium protein |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149881A1 Antibodies for gm-csf receptor and uses thereof |
| 05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | CA2149212A1 Improved recombinant production of proteins having factor viii:c activity |
| 05/26/1994 | CA2149056A1 Novel polypeptides with opioid receptor activity, nucleic acids encoding these substances and uses thereof |
| 05/26/1994 | CA2148838A1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 05/26/1994 | CA2148829A1 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis |
| 05/26/1994 | CA2148713A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
| 05/26/1994 | CA2147600A1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 05/26/1994 | CA2147122A1 Biocidal chitin binding proteins |
| 05/26/1994 | CA2138009A1 Production of monoclonal recombinant antibodies without the use of hybridomas by iin vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna |
| 05/26/1994 | CA2127531A1 Materials and methods for immunocontraception |
| 05/25/1994 | EP0598589A2 Method for the production of proteins in plant fluids |
| 05/25/1994 | EP0598329A2 Simultaneous determination of HbA1c and haemoglobin variants with a HbA1c analog glycation |
| 05/25/1994 | EP0598011A1 Ecdysteroid dependent regulation of genes in mammalian cells |
| 05/25/1994 | EP0598000A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 05/25/1994 | EP0597960A1 Treatment of cell populations |
| 05/25/1994 | EP0597852A1 Swine pneumonia vaccine and method for the preparation thereof |
| 05/25/1994 | EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
| 05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 05/25/1994 | EP0597842A1 Metal binding proteins |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0252146B1 Nuclear factors associated with transcriptional regulation |
| 05/25/1994 | CN1087122A Method for production and purification of hepatitis Bvaccine |
| 05/25/1994 | CA2103323A1 Her4 human receptor tyrosine kinase |
| 05/24/1994 | US5314996 Isolated nucleotide sequences encoding an: antigen binding site of monoclonal antibody PD41; and antigen associated with prostate adenocarcinomas |
| 05/24/1994 | US5314995 Antitumor |
| 05/24/1994 | US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen |
| 05/24/1994 | US5314872 Glucan sulfate, stabilized fibroblast growth factor composition |
| 05/24/1994 | US5314857 Microporous structure with layered interstitial surface treatment, and method and apparatus for preparation thereof |
| 05/24/1994 | US5314820 Process and microorganisms for producing single cell protein |
| 05/24/1994 | US5314817 Catalytic and reactive polypeptides and methods for their preparation and use |
| 05/24/1994 | US5314698 Isolation of brush border membrane vesicles from whole insect larvae |
| 05/24/1994 | US5314642 Hydrolysis |
| 05/24/1994 | CA1329766C T cell epitopes of the hepatitis b virus nucleocapsid protein |
| 05/24/1994 | CA1329763C Stabilized fgf composition and production thereof |
| 05/19/1994 | DE4238778A1 Vektor zur Expression von therapeutisch relevanten Genen Vector for Expression of therapeutically relevant genes |
| 05/18/1994 | EP0597827A1 Fibroblast growth factor |
| 05/18/1994 | EP0597681A1 Expression vectors for the bovine trypsin and trypsinogen and host cells transformed therewith |
| 05/18/1994 | EP0597503A2 ECK receptor ligands |
| 05/18/1994 | EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 05/18/1994 | EP0597035A1 Highly stable recombinant yeasts for the production of recombinant proteins |
| 05/18/1994 | EP0597016A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 05/18/1994 | EP0597008A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
| 05/18/1994 | EP0596979A1 Recombinant plant viral nucleic acids |
| 05/18/1994 | EP0596881A1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector. |
| 05/18/1994 | EP0380495B1 Serum free media for the growth of insect cells and expression of products thereby |
| 05/18/1994 | EP0335899B1 Immunoaffinity purification system |
| 05/18/1994 | EP0283475B1 Enhanced secretion of heterologous proteins by hosts using substituted promoters |
| 05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |